NCT05596630View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Carcinoma; Hepatocellular
Interventions
RADIATION

Stereotactic body radiation therapy

Stereotactic body radiotherapy for small intrahepatic recurrent HCC. Radiation dose: Greater than or equal to 40Gy/4-5F, complete treatment within 1 week.

Trial Locations (1)

310009

RECRUITING

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER